Strona główna・Stock List・Voyager Therapeutics Inc

Voyager Therapeutics Inc

Closed

3.19 0.63

Buy Sell

Overview

Share price change

24h

Current

Min

3.13

Max

3.32

Key metrics
By Trading Economics
Income	-511K -28M
Sales	-13M 2.6M
EPS	-0.47
Profit margin	-1,077.401
Employees	141
EBITDA	1.9M -27M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+437.97% upside

Dividends
By Acuity
Next Earnings	4 sie 2026

Market Stats
By TradingEconomics
Market Cap	-27M 208M
Previous open	2.56
Previous close	3.19

Voyager Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 lip 2026, 23:56 UTC

Correlated Moves

Skyworks Solutions Inc shares are higher in after-market trading, supported by positive sentiment in the semiconductor sector and strong earnings from major banks.

14 lip 2026, 23:56 UTC

JD.Com Inc. shares advanced in after-market trading, supported by strong earnings from major banks and a positive market backdrop. The stock remains above its 20-day moving average.

14 lip 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is higher in after-market trading, supported by favorable USD/CNH exchange rate movements and contributions from JD.

14 lip 2026, 23:56 UTC

Vanguard Total International Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 lip 2026, 23:56 UTC

iShares National Muni Bond ETF remains roughly flat in after-market trading. Global equity indices are higher following lower-than-expected U.S. inflation data.

14 lip 2026, 23:52 UTC

Verisk Analytics Inc shares are lower in after-market hours, with no specific news identified. The decline contrasts with positive sentiment from strong bank earnings.

14 lip 2026, 23:52 UTC

South Korea's June unemployment rate improves to 2.7%, boosting market confidence amid global economic recovery.

14 lip 2026, 23:52 UTC

Brazil's Central Bank to Release Key SELIC Rate Insights Amid Global Inflation Concerns on July 20, 2026.

14 lip 2026, 23:52 UTC

U.S. Industrial Production Data Release on July 17, 2026, Expected to Show Modest Growth Amid Cautious Economic Sentiment and Global Market Volatility.

14 lip 2026, 23:52 UTC

China's Q2 GDP Growth Rate Expected to Slow to 0.9% Amid Strong Export Surge and Cautious Consumer Sentiment

14 lip 2026, 23:52 UTC

Japan's upcoming Exports YoY report on July 21, 2026, is generating cautious optimism among investors amid positive regional trends and strong Chinese export data.

14 lip 2026, 23:52 UTC

Japan's Upcoming Balance of Trade Data on July 21, 2026, Sparks Cautious Investor Sentiment Amidst Persistent Trade Deficits and Global Commodity Price Fluctuations.

14 lip 2026, 23:51 UTC

U.S. Inflation Drops More Than Expected, Boosting European Equity Futures Amid Geopolitical Tensions

14 lip 2026, 23:51 UTC

U.S. inflation drops unexpectedly, boosting global equity markets despite mixed results in the U.S. and ongoing geopolitical tensions affecting oil prices.

14 lip 2026, 23:51 UTC

Asian equity markets rise on strong Chinese trade data, while U.S. stock futures react to softer inflation and mixed earnings amid geopolitical tensions.

14 lip 2026, 23:51 UTC

U.S. equity markets show mixed results as weaker-than-expected inflation data eases rate hike fears, while geopolitical tensions and strong bank earnings drive volatility.

14 lip 2026, 23:46 UTC

ETF Constituents

iShares Core MSCI EAFE ETF declines in after-market hours, influenced by top holdings BHP and TM. Performance remains flat since Tuesday's close.

14 lip 2026, 23:46 UTC

ETF Constituents

iShares Biotechnology ETF declines in after-hours trading, continuing a trend of lower daily closes amid declines from key holdings like EDIT and ADPT.

14 lip 2026, 23:46 UTC

MercadoLibre Inc shares are higher in after-market hours, supported by strong bank earnings that eased interest rate concerns. No specific news was identified for the stock.

14 lip 2026, 23:46 UTC

News

PayPal Holdings Inc. shares are lower in after-market trading despite expanding buy now, pay later options in the UK with a new Pay in 30 Days feature.

14 lip 2026, 23:42 UTC

Japan's Machinery Orders Expected to Decline by -4.2% MoM Amid Geopolitical Tensions and Market Caution

14 lip 2026, 23:42 UTC

China's Fixed Asset Investment Expected to Contract Further Amid Weak Economic Indicators and Cautious Market Sentiment

14 lip 2026, 23:42 UTC

China's Industrial Production YoY data for June 2026, expected to rise to 4.6%, set for release on July 15 amid cautious optimism influenced by strong trade figures and geopolitical tensions.

14 lip 2026, 23:42 UTC

China's Retail Sales Expected to Decline by 0.1% YoY Amid Mixed Economic Signals Ahead of July Release

14 lip 2026, 23:42 UTC

China's Q2 2026 GDP Growth Rate Expected at 4.5%, Amid Mixed Economic Signals and Global Uncertainties

14 lip 2026, 23:42 UTC

Bank of Canada's Monetary Policy Report on July 15, 2026, expected to maintain interest rates amid stable inflation and geopolitical tensions.

14 lip 2026, 23:41 UTC

Event

News

Biogen Inc shares are higher in after-market trading following positive Phase 2 CELIA study results for diranersen, which targets tau in early Alzheimer's disease.

14 lip 2026, 23:41 UTC

Macro Event

Correlated Moves

Macro News

Crude oil prices have risen, reaching $79 per barrel amid U.S.-Iran tensions. The EUR/USD exchange rate is modestly higher since Monday's close.

14 lip 2026, 23:41 UTC

Macro News

Macro Event

Correlated Moves

Bitcoin is rising as geopolitical tensions boost oil prices and soft U.S. inflation data eases rate hike fears. Ethereum's gains may further support Bitcoin's momentum.

14 lip 2026, 23:36 UTC

Autodesk Inc shares advanced after-market, reaching a high of 0.78% since Tuesday's close, despite no specific news driving the movement.

Peer Comparison

Price change

Voyager Therapeutics Inc Forecast

Price Target

By TipRanks

437.97% upside

12 Months Forecast

Average 17 USD 437.97%

High 25 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forVoyager Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Based on 6 analysts giving stock ratings to Voyager Therapeutics Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.